Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 18/20 | 0.71 |
| ▸ | NPY1R | P25929 | 12/20 | 0.71 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.71 |
| ▸ | NPY2R | P49146 | 8/20 | 0.71 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31666017 | 0.98 | NPY4R (0.71) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29901562 | 0.96 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29901565 | 0.95 | NPY4R (0.73) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29767742 | 0.94 | NPY4R (0.72) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29767744 | 0.94 | NPY4R (0.72) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30101010 | 0.94 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30827582 | 0.94 | NPY4R (0.70) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29767743 | 0.93 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31745529 | 0.92 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30310193 | 0.92 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240083943-A1 | VEGF-REGULATING PEPTIDES | IDP DISCOVERY PHARMA, S.L. (ES) | 2024-03-14 | — | — | US | disclosed |
| EP-4271480-A1 | VEGF-REGULATING PEPTIDES | IDP Discovery Pharma, S.L. (ES) | 2023-11-08 | — | — | EP | disclosed |
| WO-2022144401-A1 | VEGF-REGULATING PEPTIDES | IDP DISCOVERY PHARMA, S.L. (ES) | 2022-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083943-A1 | VEGF-REGULATING PEPTIDES | VEGFA, FLT4, FLT1 | NPY4R 62/4885NPY1R 105/4885NPY5R 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.